PPBT 股价走势图
PPBT 财务
Purple Biotech Ltd
$4.12
5.49%
$0.21
收盘价：May 08, 16:00:00 GMT-4
$3.95
-4.24%
$-0.17
盘后：May 08, 20:00:00 GMT-4
返回
Purple Biotech Ltd (PPBT) 财务
关键数据
前收盘价
$3.91
开盘价
$4.08
当日区间
$3.95 - $4.19
52周范围
$3.6 - $29
交易量
3.3K
平均成交量
13.3K
股息收益率
--
每股收益（TTM）
-54.00
市值
$3.6M
什么是 Purple Biotech Ltd.？
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 10 full-time employees. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
